LGALS3 and heart failure: Galectin-3 itself has been shown to be a novel inflammatory biomarker, which raises an intriguing question as to whether inflammation in patients without heart failure or hemodynamic disturbances is associated with increased NT-proBNP and galectin-3 or not [31].